Clinical Trial TitleParkinson's Disease Genetics in the African American Population
Clinical Trial Protocol Description:
The purpose of this study is to learn more about the genetic causes of Parkinson’s disease in Black and African American populations. Research with European and white groups have found several genes involved in the development of Parkinson’s disease. We want to know if changes in these genes are also present in Black and African American people with Parkinson’s disease, or if there are other genes that might cause Parkinson’s disease.
Your participation in this study will help researchers understand genetic information about Parkinson’s disease in Black and African Americans. BLAAC PD is part of the Global Parkinson’s Genetics Program (GP2).
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Are 18 years of age or older.
- Have a diagnosis of Parkinson’s disease by a neurologist or other qualified professional.
- Have not been diagnosis of Parkinson’s disease and/or other neurological condition and have no known family member with Parkinson’s and/or neurologic or psychiatric conditions.
- Are able to give consent, or, in the case of adults without consent capacity, have a legallyauthorized representative to provide consent.
- Donate a blood or saliva sample one time.
- Allow the doctor to perform a physical examination.
This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.
Clinical Trial Investigator
Clinical Trial Location
RUSH University Medical Center
1620 W Harrison St
Chicago, IL 60612
RUSH Copley Medical Center
2000 Ogden Ave
Aurora, IL 60504